Anissa Abi-Dargham, MD, has contributed extensively to the study of schizophrenia and schizoaffective disorders, focusing on psychopharmacology. Her publications address emerging treatments, dopamine dysfunction, and the role of neurotransmitters such as dopamine and glutamate in schizophrenia. She has collaborated frequently with authors including Christoph U. Correll, Oliver Howes, Henry A. Nasrallah, John M. Kane, and Jonathan M. Meyer. Her work has appeared in Psychiatrist.com from 2005 to 2022.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
